Compassionate use of orphan drugs

BACKGROUND: EU regulation 726/2004 authorises manufacturers to provide drugs to patients on a temporary basis when marketing authorisation sought centrally for the entire EU is still pending. Individual Member States retain the right to approve and implement such ‘compassionate use’ programmes which...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyry, Hanna I., Manuel, Jeremy, Cox, Timothy M., Roos, Jonathan C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546220/
https://www.ncbi.nlm.nih.gov/pubmed/26292942
http://dx.doi.org/10.1186/s13023-015-0306-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546220/
https://www.ncbi.nlm.nih.gov/pubmed/26292942
http://dx.doi.org/10.1186/s13023-015-0306-x

Ejemplares similares